Last $0.05 USD
Change Today +0.005 / 12.50%
Volume 950.0
QTXB On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 10/30/14 All times are local (Market data is delayed by at least 15 minutes).

quantrx biomedical corp (QTXB) Snapshot

Open
$0.05
Previous Close
$0.04
Day High
$0.05
Day Low
$0.05
52 Week High
04/16/14 - $0.11
52 Week Low
12/27/13 - $0.0070
Market Cap
2.9M
Average Volume 10 Days
55.7K
EPS TTM
$-0.0030
Shares Outstanding
63.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for QUANTRX BIOMEDICAL CORP (QTXB)

Related News

No related news articles were found.

quantrx biomedical corp (QTXB) Related Businessweek News

No Related Businessweek News Found

quantrx biomedical corp (QTXB) Details

QuantRx Biomedical Corporation focuses on the development and commercialization of diagnostic products for the healthcare industry worldwide. The company offers PAD based products for the over-the-counter and laboratory markets based on its patented technology platforms; and its genomic diagnostics, based on its patented PadKit technology. Its product and product candidates include PADKit that contains a miniform used as a collection device to collect a sample for vaginal diagnostic evaluation for indications, such as HPV, human immunodeficiency virus, and general health screening; and Unique miniform, which is available as a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad, for the daily protection of light urinary, vaginal, or anal leakage. The company was incorporated in 1986 and is based in Tualatin, Oregon.

quantrx biomedical corp (QTXB) Top Compensated Officers

Chairman, Chief Executive Officer and Princip...
Total Annual Compensation: $2.0K
Compensation as of Fiscal Year 2013.

quantrx biomedical corp (QTXB) Key Developments

QuantRx Biomedical Corporation announced delayed 10-Q filing

On 08/14/2014, QuantRx Biomedical Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

QuantRx Biomedical Corporation announced delayed 10-Q filing

On 05/15/2014, QuantRx Biomedical Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

QuantRx Biomedical Corporation announced delayed annual 10-K filing

On 03/31/2014, QuantRx Biomedical Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QTXB:US $0.05 USD +0.005

QTXB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for QTXB.
View Industry Companies
 

Industry Analysis

QTXB

Industry Average

Valuation QTXB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 732.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 455.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUANTRX BIOMEDICAL CORP, please visit www.quantrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.